Please login to the form below

Not currently logged in
Email:
Password:

Ferring outlines US expansion plans

Swiss pharma company to develop corporate centre in New Jersey

Swiss pharma company Ferring Pharmaceuticals is increasing its US footprint with an expanded operations centre.

The new facility will house management, administration and support, commercial operations, manufacturing and product development.

Located in Parsippany, New Jersey the 25-acre site will also include a state-of-the-art manufacturing suite, next-generation product development laboratories, a fully equipped education and training conference centre, and administrative offices.

Aaron Graff, president and chief operating officer of Ferring Pharmaceuticals Inc, said: "As a private company, Ferring has a long term orientation, as well as a commitment to follow the science to benefit patients. This new facility underscores our long-term commitment to the US market, as well as the State of New Jersey.

"Together with our Global Research Center in San Diego, this symbolises our focus on accelerating Ferring growth in the United States.”

The Switzerland-based company's US subsidiary has experienced consistent double-digit growth and has approximately 600 employees.

22nd November 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

Where next in Alzheimer’s disease R&D?
How past failures and emerging biology are reshaping drug development...
Brain scan
Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...
Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...

Infographics